000			03655cam a22004698i 4500
001			23359853
005			20241127162448.0
006			m |o d |
007			cr_|||||||||||
008			231020s2024 enk o 001 0 eng
010			_a 2023049331
020			_a9781009282406 _q(epub)
020			_z9781009282383 _q(hardback)
020			_z9781009282376 _q(paperback)
040			_aDLC _beng _cDLC _erda
042			_apcc
245	0	0	_aIntellectual property, COVID-19, and the next pandemic : _bdiagnosing problems, developing cures / _cedited by Haochen Sun, The University of Hong Kong; Madhavi Sunder, Georgetown University, Washington DC.
263			_a2405
264		1	_aCambridge , United Kingdom ; _aNew York, NY : _bCambridge University Press, _c2024.
300			_a1 online resource
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
500			_aIncludes index.
505	0		_aPeter Lee, New and heightened public-private quid pro quos : leveraging public support to enhance private technical disclosure -- Lawrence O. Gostin, Global medical war chest -- Laura G. Pedraza-Fariña, COVID-19 and boundary-crossing collaboration -- Matthew M. Kavanagh and Renu Singh, Legal paradigms and the politics of global COVID-19 vaccine access -- William Fisher, Ruth Okediji, and Padmashree Gehl Sampath, Fostering production of pharmaceutical products in developing countries -- Haochen Sun, Patent Philanthropy -- Cynthia M. Ho, Beyond traditional IP : addressing regulatory barriers -- Calvin WL Ho, Capability approach to developing global health initiatives for equitable access to vaccines -- Sapna Kumar & Ana Santos Rutschman, Planning for pandemic and epidemic-related scarcity of medicines related scarcity of medicines -- Jayashree Watal, Improving global governance of pandemic response : lessons from COVID-19 -- David S. Levine & Joshua D. Sarnoff, Compelling trade secret sharing -- Jorge L. Contreras, voluntary intellectual property pledges and COVID-19 -- Peter K. Yu, China, The TRIPS waiver and the global pandemic response -- Olufunmilayo Arewa, COVID-19 exclusion, policy contagion, and colonial hangover in Africa -- Kenneth C. Shadlen, Technology transfer for production of COVID-19 vaccines in Latin America.
520			_a"This volume critically assesses the role of intellectual property in pandemic times through lessons learned from the COVID-19 pandemic. It broadens our understanding of the implications of intellectual property protection for both the development and distribution of essential technologies such as vaccines"-- _cProvided by publisher.
588			_aDescription based on print version record and CIP data provided by publisher; resource not viewed.
650		0	_aIntellectual property (International law)
650		0	_aVaccines _vPatents.
650		0	_aCOVID-19 (Disease) _xLaw and legislation..
650		0	_aCOVID-19 Pandemic, 2020-
650		0	_aPublic health laws, Inernational.
650		0	_aEpidemics.
650		0	_aVaccines _xHealth aspects.
700	1		_aSun, Haochen, _eeditor.
700	1		_aSunder, Madhavi, _eeditor.
776	0	8	_iPrint version: _tIntellectual property, COVID-19, and the next pandemic _dCambridge , United Kingdom ; New York, NY : Cambridge University Press, 2024 _z9781009282383 _w(DLC) 2023049330
856			_uhttps://www.cambridge.org/core/books/intellectual-property-covid19-and-the-next-pandemic/C9DE9042D016A4BF9C1D4F09C2F70091 _yClick here to Access
906			_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg
942			_2ddc _cOAB
999			_c213063 _d213063